The Trump administration has issued a flurry of orders and is negotiating with pharmaceutical companies to lower drug prices. Experts say the actions will do little to bring down prices for consumers. https://t.co/1aC9MI2PT1 ...

Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news about prices for some drugs and the medication payment plan. https://t.co/KkwSFYdsJC ...

Astroenica, the largest pharmaceutical manufacturer in the United Kingdom, is committing to offer Americans major discounts on their vast catalog of prescription drugs. One of the great companies, by the way, and a most favored nation's pricing clause. So, most favored nation is uh you're going to pay whatever the lowest price anywhere in the world is.That's what you're going to be paying. ...

Government Policy & Drug Pricing - Melissa Astroenetica becomes the second drug maker to join President Trump's most favored nation drug price program [1] - The administration aims to align 95% of US drug prices with European levels [3] - Fizer reached an agreement to provide drugs at lower prices for Medicaid and invest $70 billion in the US, in exchange for tariff exemption for three years [2] - CMS administrator Dr Oz is central to these negotiations [1][2] - The next round of IRA price negotiation prices will be available next month [5] Company Investment & Operations - Melissa Astroenetica is breaking ground on a $45 billion plant in Virginia [1] - Fizer is making a $70 billion investment in the US, including manufacturing [2] Future Outlook & Negotiation Strategies - The administration is reaching out to many firms regarding drug pricing [3] - Medicare innovation pilots are being considered to address drug prices [5] - Dr Ash indicates that Medicare is also being considered [4] - The team is negotiating aggressively on drug prices [5]

Industry Dynamics - AstraZeneca is expected to announce a deal with Trump to slash drug prices [1] - AstraZeneca 将成为第二家与特朗普达成协议以推进其关键健康优先事项的制药公司 [1]

Industry Impact - The pharmaceutical industry is experiencing a shift due to the Pfizer deal, potentially impacting drug pricing policies [1] - The deal allows the Trump administration to demonstrate progress in addressing perceived unfair foreign freeloading on high drug prices paid by Americans [1]

Agreement Overview - Pfizer reached an agreement with the White House to lower drug costs for Americans in exchange for not facing tariffs for the next three years, provided they increase their manufacturing in the US [2] - The agreement is a result of the most favored nation drug pricing order established earlier this year [2] - President Trump expects deals with other companies in the forthcoming several weeks [6] Pricing and Savings - Fizer will offer countless prescription medications at major discounts in the United States [2] - The majority of Fizer's primary care drugs and some select specialty brands will be offered with a 50% savings rate, with some savings on select drugs as high as 85% [5] - Consumers can expect these lower drug prices to kick in early next year [7] Trump RX Portal - A new government website called Trumprx gov is being developed to allow consumers to find the lowest price for drugs and then be redirected to the manufacturer to buy directly [5][8][9] - The aim is to launch the website in early 2026 [8] - The government is not getting into the business of drug distribution [9] Financial Implications - Negotiations have been fierce as company's goal is to create shareholder value and wealth, and lowering drug prices doesn't exactly go towards that [7] - As new drugs are launched in the US, they are expected to be launched at the lowest possible price with drugs launched in other countries at higher prices [7] - A portion of the profits that these drug makers earn from sales overseas will be given back to US patients, likely through the program of Medicare [7]

Today, Fiser is committing to offer all of their prescription medications to Medicaid, and it will be at the most favored nation's prices. It's going to have a huge impact on bringing Medicaid costs down. This is a critical step forward to our work and to improve healthcare and hardworking lowincome Americans, especially low-income Americans, will be helped so greatly.In addition, Fiser is agreeing to provide some of their most popular current medications to all consumers at heavily discounted prices of any ...

Pharmaceutical Industry Dynamics - The White House and President Trump have been pushing for lower prescription drug costs for months, culminating in an announcement with Pfizer [2] - The administration's overall goal is to lower US prescription drug costs, which are historically higher than in other nations [3] - President Trump announced a deal between Medicaid and Pfizer to lower drug prices, along with a new website called Trump RX for Americans to buy medications [1] Pfizer Deal Specifics - Pfizer has pledged to lower some prescription drug costs, but the specific drugs involved are not yet known [2][3] - The CEO of Pfizer is in attendance and will offer remarks, with other drug makers potentially following suit [3][5] Trump RX Website - Trump RX is intended to be a direct-to-consumer website named after the president [4] - Details on how the Trump RX website will work and which drugs will be included are still pending [4][5] - The aim is to cut out intermediaries and allow people to order prescription drugs directly through Pfizer [5]

Today, Pfizer's committing to offer all of their prescription medications to Medicaid, and it will be at the most favored nations. Prices is going to have a huge impact on bringing Medicaid costs down like nothing else. I told you that in my first term, I was so proud of the fact that for the first time in 28 years, drug prices came down and I had a news conference that explained it was 1/10 of 1%, but it was down.And here we're talking about, in one case, over 1,000%. This is a critical step forward to wor ...